Local microwave ablation with continued EGFR tyrosine kinase inhibitor as a treatment strategy in advanced non-small cell lung cancers that developed extra-central nervous system oligoprogressive disease during EGFR tyrosine kinase inhibitor treatment: A pilot study

Documenti analoghi

• Microwave ablation with continued EGFR tyrosine kinase inhibitor therapy prolongs disease control in non‐small‐cell lung cancers with acquired resistance to EGFR tyrosine kinase inhibitors
  di: Li, Xin, et al.
  Pubblicazione: (2018)
• Microwave ablation combined with EGFR-TKIs versus only EGFR-TKIs in advanced NSCLC patients with EGFR-sensitive mutations
  di: Wei, Zhigang, et al.
  Pubblicazione: (2017)
• Mechanisms of resistance to EGFR tyrosine kinase inhibitors
  di: Huang, Lihua, et al.
  Pubblicazione: (2015)
• Skin problems and EGFR-tyrosine kinase inhibitor
  di: Kozuki, Toshiyuki
  Pubblicazione: (2016)
• Redundant kinase activation and resistance of EGFR-tyrosine kinase inhibitors
  di: Luo, Min, et al.
  Pubblicazione: (2014)